In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 12th, 2006 | 25 | No |
Popular Name: Medroxyprogesterone Medroxyprogesterone
Find On: PubMed — Wikipedia — Google
CAS Number: 520-85-4
(6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione
17 alpha Hydroxy 6 alpha Methylprogesterone
17 alpha-Hydroxy-6 alpha-Methylprogesterone
17-Hydroxy-6-methylpregn-4-ene-3,20-dione; LS-118711; Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-
17-Hydroxy-6.alpha.-methylprogesterone
17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6alpha-methylprogesterone
17.alpha.-Hydroxy-6.alpha.-methylprogesterone
17alpha-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione
17alpha-Hydroxy-6alpha-methylprogesterone
4-08-00-02211 (Beilstein Handbook Reference)
520-85-4; C07119; Medroxyprogesterone
520-85-4; D08166; Farlutal inyectable (TN); Medroxyprogesterone (INN)
6-alpha-Methyl-17-alpha-hydroxyprogesterone
6.alpha.-Methyl-17.alpha.-hydroxyprogesterone
6alpha-Methyl-17alpha-hydroxyprogesterone
6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione
6alpha-Methyl-5-pregnen-17alpha-ol-3,20-dione
CPD000058769; MEDROXYPROGESTERONE
CPD000058769; MEDROXYPROGESTERONE; SAM001246906
Depot-Medroxyprogesterone acetate
Medroxiprogesterona [INN-Spanish]
medroxiprogesterona; medroxyprogesterone; medroxyprogesteronum
Medroxyprogesterone Strakan Brand
Medroxyprogesteronum [INN-Latin]
Pregn-4-ene-3,20-dione, 17-hydroxy-6-alpha-methyl-
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6-alpha)-
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6-alpha)- (9CI)
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6.alpha.)-
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)-
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)- (9CI)
Pregn-4-ene-3,20-dione, 17-hydroxy-6.alpha.-methyl-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.34 | 7.96 | -9.5 | 1 | 3 | 0 | 54 | 344.495 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.54e-02 g/l | DrugBank-approved |
PUBCHEM_PATENT_ID | EP0153001A2; EP0153001B1; EP0268400A1; EP0268400B1; US3935860; US3971367; US3993057; US4154748; US4177269; US4181721; US4188951; US4237885; US4286587; US4383992; US4500461; US4548748; US4578076; US4585590; US4831131; US4921638; US4977255 | IBM Patent Data |
Patent Database Links | EP1550447; EP1800666; EP1862167; EP1872775; GB2321455; US2001006962; US2002028799; US2003153544; US2004063677; US2005002945; US2005054656; US2005176772; US2006041014; US2007190160; US2007207141; US2007212392; US2007253899; US2007254853; US2007258969; WO20 | ChEBI |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sigma Chemical Company; NCC_SUPPLIER_STRUCTURE_ID : M6013 | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sigma Chemical Company; SUPPLIER_STRUCTURE_ID: M6013 | NIH Clinical Collection via PubChem |